Table of Contents

company-logo

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.

XTL Biopharmaceuticals Dividend Announcement

• XTL Biopharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on XTL Biopharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

XTL Biopharmaceuticals Dividend History

XTL Biopharmaceuticals Dividend Yield

XTL Biopharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing XTL Biopharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

XTL Biopharmaceuticals Financial Ratios

P/E ratio-27.10
PEG ratio0.99
P/B ratio3.79
ROE-14.91%
Payout ratio0.00%
Current ratio11.43
Quick ratio11.43
Cash Ratio4.79

XTL Biopharmaceuticals Dividend FAQ

Does XTL Biopharmaceuticals stock pay dividends?
XTL Biopharmaceuticals does not currently pay dividends to its shareholders.
Has XTL Biopharmaceuticals ever paid a dividend?
No, XTL Biopharmaceuticals has no a history of paying dividends to its shareholders. XTL Biopharmaceuticals is not known for its dividend payments.
Why doesn't XTL Biopharmaceuticals pay dividends?
There are several potential reasons why XTL Biopharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will XTL Biopharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While XTL Biopharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is XTL Biopharmaceuticals a dividend aristocrat?
XTL Biopharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is XTL Biopharmaceuticals a dividend king?
XTL Biopharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is XTL Biopharmaceuticals a dividend stock?
No, XTL Biopharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy XTL Biopharmaceuticals stocks?
To buy XTL Biopharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy XTL Biopharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.